A Systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas
Marina Chan, Songli Zhu, Zachary R. Russell, Sonali Arora, Aleena K. S. Arakaki, Joel Markus Vaz, Deby Kumasaka, Frank Szulzewsky, Kulandaimanuvel Antony Michealraj, Eric C. Holland, Taranjit S. Gujral
This study identifies MERTK as a therapeutic target in ZFTA-RELA-driven ependymomas through transcriptomic analysis and drug screening.
Proceedings of the National Academy of Sciences · Feb 10, 2026Peer-reviewedCancer Biology